Stratophase wins

Published: 1-Feb-2010
Manufacturing Regulatory Finance Analysis

Stratophase, a UK specialist in chemical and biochemical measurement and detection, has secured

Stratophase, a UK specialist in chemical and biochemical measurement and detection, has secured £2.5m of follow-on funding from existing investor East Hill Management of Providence, Rhode Island in the US.

The additional investment will enable the company, a spin-out from Southampton University, to roll out its SpectroSens real-time monitoring technology, recruit key staff and move to larger premises.

The SpectroSens optical microchip technology is being developed for a number of applications in process measurement and bio-detection, including in-line monitoring of pharmaceutical manufacturing (both small molecule and bio-pharmaceuticals).

The company says a multinational pharmaceutical company is currently evaluating the system.

Stratophase is headed by ceo Dr Richard Williams.




See more

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Focusing on next-generation biologics

Read more
Outsourced adaptive control techniques are set to minimise development timelines and enhance process robustness

Trending Articles

  1. Roche wins CE mark for first blood-based immunoassay to identify ApoE4 Alzheimer's risk variant Roche's Elecsys ApoE4 test has received CE mark approval as the first in-vitro diagnostic immunoassay to detect the ApoE4 genetic variant from a simple blood sample, potentially eliminating the need for confirmatory DNA testing in Alzheimer's patients who do not carry the variant
  2. You need to be a subscriber to read this article.
    Click here to find out more.
    Moving with speed and scale: innovative, material-sparing approaches to accelerate clinical development As early-stage drug development is often hindered by limited API supply, rising costs and tight timelines, material-sparing technologies are helping companies to progress faster with less
  3. Why weight sorting should move earlier in OSD development Phillip Ruda explains how earlier weight intelligence can improve process understanding, reduce risk and accelerate learning cycles
  4. Orphan drug sales to exceed $400bn by 2032, Evaluate report finds Despite FDA policy shifts and the rise of blockbuster obesity drugs, a new Evaluate report confirms rare disease therapies are on track to claim more than a fifth of all global prescription drug sales within a decade

Upcoming event

DCAT Week

23–26 March 2026 | Conference | New York, US See all

You may also like

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Focusing on next-generation biologics

Outsourced adaptive control techniques are set to minimise development timelines and enhance process robustness
You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

Bioprocess control in line using optical sensing

Process Analytical Techniques (PAT) and Quality by Design (QbD) initiatives are leading the industry to adopt real-time, continuous monitoring techniques that allow better knowledge from inside the process. Historically, process control has been a combination of real-time physical data and off-line, lab-based, analytical sampling with process quality determined after the process is completed. Stratophase has introduced a real-time, in-line optical media sensor that monitors the media’s status and automates glucose feeding
Analysis

Stratophase Ranger enables automated batch feeding

To optimise metabolism and ultimately increase yields in biologics manufacture
You need to be a subscriber to read this article.
Click here to find out more.
Analysis

Get an in-line view with optical fibres

New real time, in-line measurement technologies developed from fibre optics can improve biopharmaceutical process control, enhancing production efficiency, quality and safety by reducing production cycle times, minimising batch rejection, enabling real-time release, increasing the use of automation and facilitating continuous processing. In-line, real-time measurement techniques that provide status monitoring are now being developed to provide the required analytical measurements from within the fermentation media.
Regulatory

Stratophase doubles manufacturing capability

Result of increased demand for SpectroSens technology
Manufacturing

Clariant opens first US pharmaceutical-grade PEG excipient manufacturing site in Texas

Clariant has expanded its Clear Lake facility in Texas to produce GMP-compliant pharmaceutical-grade polyethylene glycol excipients, marking its first US-based manufacturing site for the products and strengthening supply chain resilience for North American and Latin American pharma customers
Design & Build

ESTEVE CDMO expands spray drying and high-potency containment capacity at Girona facility

ESTEVE CDMO has announced plans to add a 3000-square-metre production unit at its Celrà site in Spain to house additional spray drying equipment and high-potency containment suites, with the first new GEA spray dryer due online in Q1 2027
Subscribe now